Delivery Order SPE2DB25D3006-SPE2DB25FXHQL
Award Date
3/26/25
Potential Completion Date
3/27/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,356.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of VYVANSE 30 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of March 20, 2025 and a firm fixed price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,276.40, is for the supply of VYVANSE 50 MG CAPSULE 100S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 5, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $4,392.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,052,546 units of VYVANSE 30 MG CAPSULE 100S, a prescription medication, with a completion date of March 4, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award, valued at $3,432.21, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB24D1007|SPE2DB25FCADR) for the supply of 4,567,155,179 units of the medication VYVANSE 30 MG CAPSULE 100S. The contract has a firm fixed price and an ultimate completion date of February 5, 2025. This award is part of a larger Indefinite Delivery Contract...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4,566,196,313 units of VYVANSE CAPS 30MG, a prescription medication. The contract has a firm fixed price of $13,819.32 and a completion date of October 25, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at...
This federal contract award, valued at $1,720.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567553029 ! VYVANSE 30 MG CAPSULE 100S, a pharmaceutical product. This contract is a delivery order and has a firm fixed price pricing type. The contract has an ultimate completion date of March 12, 2025 and was awarded on March 11, 2025. The contract does not...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,908.04 firm fixed-price delivery order is for the supply of 4567059430 - VYVANSE 30 MG CAPSULE 100S, with a period of performance through January 28, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award, valued at $3,682.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4567697977 VYVANSE 30 MG CAPSULES 100S, with a firm fixed price and an ultimate completion date of March 27, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, valued at $4,288.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4567558069 - VYVANSE 30 MG CAPSULE 100S, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,994.76 firm fixed-price delivery order is for the supply of VYVANSE 30 MG CAPSULE 100S, with a period of performance through October 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...